The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns of disease progression to checkpoint inhibitor immunotherapy in patients with stage IV non-small cell lung cancer.
 
Naomi Fei
No Relationships to Disclose
 
Christina Attia
No Relationships to Disclose
 
Mohammed Almubarak
No Relationships to Disclose
 
Patrick C. Ma
Stock and Other Ownership Interests - Cymeta Biopharmaceutical
Consulting or Advisory Role - Apollomics; AstraZeneca; Takeda
Speakers' Bureau - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck; Takeda
Research Funding - Abbvie (Inst); Apollomics (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Cymeta Biopharmaceutical (Inst); EpicentRx (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); OncoMed (Inst); Pfizer (Inst); Tesaro (Inst); Xcovery (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences
 
Malcolm David Mattes
No Relationships to Disclose